companydata.dkcompanydata.dk

FERTIN PHARMA A/S: Financial statements 2021

CVR: 25834844

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 932,545,000 and a net result of DKK 37,642,000 compared with DKK 155,411,000 the year before. That is a decrease of 5.9% compared with the year before. The profit margin was 4%. Equity in the 2021 report amounted to DKK 681,404,000. The solvency ratio was 33.7%. The company had 569 employees in the financial year.

Revenue
DKK 932,545,000
Gross Profit
DKK 161,384,000
Profit/Loss
DKK 37,642,000
Equity
DKK 681,404,000
Total Assets
DKK 2,021,489,000
Employees
569

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021932.5M161.4M37.6M681.4M569
2020991.1M246.4M155.4M770.1M674
2019881.6M190.8M81.3M778.3M661
2018812.5M121.4M45.8M896M609
2017867.7M208.5M106.4M770.5M572

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like FERTIN PHARMA A/S

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Michael Henrik Thomsen joins the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Michael Henrik Thomsen has joined the board of directors of FERTIN PHARMA A/S.

Peter Andreas Lund Dahl Jacobsen joins the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Peter Andreas Lund Dahl Jacobsen has joined the board of directors of FERTIN PHARMA A/S.

Peter Halling joins the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Peter Halling has joined the board of directors of FERTIN PHARMA A/S.

Lene Lind joins the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Lene Lind has joined the board of directors of FERTIN PHARMA A/S.

Lars Bang leaves the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Lars Bang has left the board of directors of FERTIN PHARMA A/S.

Claus Bagger-Sørensen leaves the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Claus Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.

Rikke Kjær Nielsen leaves the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Rikke Kjær Nielsen has left the board of directors of FERTIN PHARMA A/S.

Manfred Scheske leaves the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Manfred Scheske has left the board of directors of FERTIN PHARMA A/S.

Frank Charles Condella Jr leaves the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Frank Charles Condella Jr has left the board of directors of FERTIN PHARMA A/S.

Carsten Skou leaves the board of FERTIN PHARMA A/SSep 15, 2021

As of September 15, 2021, Carsten Skou has left the board of directors of FERTIN PHARMA A/S.

About FERTIN PHARMA A/S

FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.

Source: annual report 2025, Danish Business Authority